澳洲科學家研發出新型幹細胞心臟療法
Australian Scientists Develop New Stem Cell Heart Therapy
澳洲科學家正引領一場醫學革命，研發出旨在修復受損心臟組織的新型幹細胞療法。
Australian scientists are spearheading a medical revolution with new stem cell therapies designed to repair damaged heart tissue.
心血管疾病仍是全球首要死因，但現有的心臟移植等治療手段受限於器官短缺與高昂費用。
Cardiovascular disease remains the leading cause of death globally, but current treatments like heart transplants are hindered by organ shortages and high costs.
2026年3月，生技公司Ibnova Therapeutics成立，旨在於未來五年內推動幹細胞治療進入人體臨床試驗。
In March 2026, the biotech company Ibnova Therapeutics was launched to advance stem cell treatments into human clinical trials within the next five years.
Enzo Porrello教授和James Hudson教授等研究人員已成功將實驗室培育的心肌應用於動物模型以恢復功能。
Researchers such as Professor Enzo Porrello and Professor James Hudson have successfully used lab-grown heart muscle in animal models to restore function.
一大障礙是心律不整（ㄉㄧㄢˋ）的風險。
A major obstacle has been the risk of abnormal heart rhythms, or arrhythmias.
然而，James Chong教授的團隊近期找到分離安全細胞並控制心律的方法，為更安全的術程鋪平道路。
However, Professor James Chong's team recently identified ways to isolate safe cells and control these rhythms, paving the way for safer procedures.
此外，雪梨科技大學的研究人員正透過患者自身細胞製成的3D生物列印心臟補片進行創新。
Furthermore, researchers at the University of Technology Sydney are innovating with 3D-bioprinted heart patches made from a patient's own cells.
透過結合國際合作與尖端生物技術，澳洲研究人員正更加接近於為那些過去絕望的患者提供救命的選擇。
By combining international collaboration and cutting-edge biotechnology, Australian researchers are moving closer to offering life-saving options for patients who previously had no other hope.
